AMRZ – amrize ltd ordinary shares (US:NASDAQ)

News

Amrize (NYSE:AMRZ) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Amrize (NYSE:AMRZ) was downgraded by analysts at Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
Amrize Announces Date for Fourth Quarter and Full-Year 2025 Financial Results  
What Makes Amrize (AMRZ) a Strong Investment? [Yahoo! Finance]
Amrize (NYSE:AMRZ) was given a new $64.00 price target on by analysts at Oppenheimer Holdings, Inc..
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com